Author

B. San Antonio

Institution: Eli Lilly (United States)

Observed institution: Eli Lilly (United States)

OpenAlex ID: A5126217244

Abstract PS1-08-08: monarchE: subgroup analysis of adjuvant abemaciclib + endocrine therapy for HR+, HER2-, high-risk early breast cancer by nodal status

2026 · J. Cortes, S. R. D. Johnston, et al. · Clinical Cancer Research

Works count: 1

Citation count:

H-index:

I10-index: